Pricing Log in Create free account
Friday 6 November 2026 Export VRDN’s income statement to Excel — free account

Viridian Therapeutics, Inc.

VRDN Healthcare Biotechnology

Viridian Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $70.8 million, up 23,359.9% from fiscal 2024.

Revenue
−63.5%
EPS
−5.00%
Free cash flow
−9.92%
Total debt
+1,064.9%

Quarter to September 2026, against a year earlier

29.15 0.60 +2.10%
Market cap
$3.2B
P/E
0.0×
Fwd P/E
−6.2×
Dividend yield
—
F-score
3/9
Altman Z
6.69
Beneish M
n/a
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Viridian Therapeutics, Inc. (VRDN) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Viridian Therapeutics, Inc. (VRDN) trades at a P/S ratio of 118×. Over the past ten years it has ranged from 0.5× (November 2016) to 5,781× (September 2025); the current reading is higher than 70% of that period. That is above the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 37.2× (99.14%)
FY2024 4,309× 35.27%
FY2023 3,186× 517.28%
FY2022 516× 548.93%
FY2021 79.5× 162.31%
FY2020 30.3× 799.20%
FY2019 3.4× (68.49%)
FY2018 10.7× (78.42%)
FY2017 49.6× 5,343.72%
FY2016 0.9× (61.84%)

Quarterly newest first

Period P/S ratio Change
Sep 2026 84.4× 203.02%
Jun 2026 27.9× (1.16%)
Mar 2026 28.2× (24.32%)
Dec 2025 37.2× 49.40%
42 more quarters

Against its own ten years

Low 0.5× High 5,781×
Ten-year median 34.1×
Current reading's percentile 67

P/S ratio against peers

Company P/S ratio
VKTX Viking Therapeutics, Inc. compare n/m
CELC Celcuity, Inc. compare n/m
DYN Dyne Therapeutics, Inc. compare n/m
ELVN Enliven Therapeutics, Inc. compare n/m
TARS Tarsus Pharmaceuticals, Inc. compare 4.6×
IDYA IDEAYA Biosciences, Inc. compare 86.7×
VRDN Viridian Therapeutics, Inc. 118×
DNLI Denali Therapeutics Inc. compare 165×
TLX Telix Pharmaceuticals Limited compare —
Biotechnology industry median 9.2×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on VRDN